IAM
ABBV icon

Impact Asset Management’s AbbVie ABBV Stock Holding History

Impact Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$6.63M Buy
31,630
+1,380
+5% +$268K 2.6% 11
2024
Q4 		$5.38M Sell
30,250
-1,430
-5% -$263K 2.12% 19
2024
Q3 		$6.26M Buy
+31,680
New +$5.91M 2.41% 18

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Impact Asset Management's ABBV Position: Q1 2025 in Review

Impact Asset Management increased its AbbVie (ABBV) stake by 4.6% in Q1 2025, buying an estimated $268K and bringing the position to 31,630 shares worth $6.63M. The position accounts for 2.6% of the portfolio, ranked #11.

Impact Asset Management first reported a position in ABBV in Q3 2024 and has held it in 3 quarters since. 3,819 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

  • Impact Asset Management held 31,630 shares of AbbVie worth $6.63M as of Q1 2025.
  • Impact Asset Management bought 1,380 AbbVie shares in Q1 2025, an estimated $268K.
  • AbbVie made up 2.6% of Impact Asset Management's portfolio in Q1 2025, its #11 holding.
  • Impact Asset Management first reported a position in AbbVie in Q3 2024 and has held it in 3 quarters since.
  • 3,819 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on Impact Asset Management's 13F filing for Q1 2025, filed 14 Aug 2025.